Press Releases

CMTA’s Press Room Is Where We Share News That Shapes Not Only the Future of CMT Research but Real Impact Today. From Funding Announcements to Trial Updates, This Is Where Progress Moves From Idea to Action.

CMTA Welcomes Science Writer to Staff

CMTA welcomed Kenneth Raymond to the team as a science writer, bringing a patient-centered perspective…

Release Date: April 26, 2023

Read This Press Release
CMTA Funds Preclinical Study in CMT1B

CMTA has funded a preclinical study exploring whether modulating the unfolded protein response (UPR) can…

Release Date: April 25, 2023

Read This Press Release
Sperm Donor Passes CMT Gene to Multiple Families

A sperm donor unknowingly carrying a gene associated with CMT passed the variant on to…

Release Date: April 20, 2023

Read This Press Release
Drug Development Expert Martine Garnier Joins STAR Advisory Board

CMTA appoints drug development expert Martine Garnier, PhD, EMBA, to its STAR Advisory Board, strengthening…

Release Date: March 30, 2023

Read This Press Release
Nonprofit Fundraising Leader Craig Zeltsar Joins CMTA Board

CMTA has welcomed Craig Zeltsar to its Board of Directors, bringing decades of nonprofit fundraising…

Release Date: December 20, 2022

Read This Press Release
CMTA, Shift Pharmaceuticals Partner on ASO Treatment for CMT1A

CMTA has partnered with Shift Pharmaceuticals to evaluate an antisense oligonucleotide (ASO) for the treatment…

Release Date: November 3, 2022

Read This Press Release
CMTA Launches CMT Awareness Month 2022

CMTA kicks off CMT Awareness Month 2022 with a month-long series of educational and community-driven…

Release Date: September 1, 2022

Read This Press Release
Software Entrepreneur Jon Pastor Joins CMTA Board

CMTA has appointed software entrepreneur Jon Pastor to its Board of Directors, adding leadership experience…

Release Date: June 23, 2022

Read This Press Release
Katherine Forsey Appointed CMTA Chief Research Officer

CMTA has appointed Katherine Forsey, PhD, as its first Chief Research Officer, reflecting the continued…

Release Date: June 22, 2022

Read This Press Release
CMTA Earns Perfect Charity Navigator Rating

CMTA has earned a perfect score from Charity Navigator, receiving a four-star rating for financial…

Release Date: February 23, 2022

Read This Press Release
CMTA Seed Funding Leads to NIH Support for CMT2 Research

CMTA seed funding has helped secure additional NIH support for two CMT type 2 research…

Release Date: December 14, 2021

Read This Press Release
CMTA-STAR Awards $354,826 for CMT Clinical Trial

CMTA-STAR has awarded $354,826 to support a clinical trial evaluating L-serine in patients with Hereditary…

Release Date: December 7, 2021

Read This Press Release